📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis. (2019)

First Author: Al-Chalabi A

Attributed to: STRENGTH funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/fjc.0000000000000728

PubMed Identifier: 31730560

Publication URI: http://europepmc.org/abstract/MED/31730560

Type: Journal Article/Review

Volume: 74

Parent Publication: Journal of cardiovascular pharmacology

Issue: 5

ISSN: 0160-2446